Dementia and Alzheimer disease incidence: A prospective cohort study

Archives of Neurology

Volumn 59, Issue 11, 2002, Pages 1737-1746

  Kukull, Walter A ^a   Higdon, Roger ^a   Bowen, James D ^a   McCormick, Wayne C ^a   Teri, Linda ^a   Schellenberg, Gerard D ^a,b   Van Belle, Gerald ^a   Jolley, Lance ^a   Larson, Eric B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Veterans Administration   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; DEMENTIA; DISEASE DURATION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; COHORT STUDIES; CONFIDENCE INTERVALS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036845531     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.11.1737     Document Type: Article

References (49)

1. Schoenberg BS, Kokmen E, Okazaki H. Alzheimer's disease and other dementing illnesses in a defined United States population: Incidence rates and clinical features. Ann Neurol. 1987;22:724-729.
2. Rocca WA, Cha RH, Waring SC, Kokmen E. Incidence of dementia and Alzheimer's disease: A reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol. 1998;148:51-62.
3. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham study. Neurology. 1993;43(pt 1):515-519.
4. Fried LP, Borhani NO, Enright P, et al. The Cardiovascular Health Study: Design and rationale. Ann Epidemiol. 1991;1:263-276.
5. Kawas C, Gray S, Brookmeyer R, Fozard J, Zonderman A. Age-specific incidence rates of Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology. 2000;54:2072-2077.
6. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-Year contribution to the understanding of health among women. J Womens Health. February 1997;6:49-62.
7. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;273:1354-1359.
8. Tang MX, Cross P, Andrews H, et al. Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56:49-56.
9. Hendrie HC, Ogunniyi A, Hall KS, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739-747.
10. Ganguli M, Dodge HH, Chen P, Belle S, DeKosky ST. Ten-year incidence of dementia in a rural elderly US community population: The MoVIES Project. Neurology. 2000;54:1109-1116.
11. Fillenbaum GG, Heyman A, Huber MS, et al. The prevalence and 3-year incidence of dementia in older black and white community residents. J Clin Epidemiol. 1998;51:587-595.
12. Havlik RJ, lzmirlian G, Petrovitch H, et al. APOE-E4 predicts incident AD in Japanese-American men: The Honolulu-Asia Aging Study. Neurology. 2000;54:1526-1529.
13. Brayne C, Best N, Muir M, Richards SJ, Gill C. Five-year incidence and prediction of dementia and cognitive decline in a population sample of women aged 70-79 at baseline. Int J Geriatr Psychiatry. 1997;12:1107-1118.
14. Fratiglioni L, Launer LJ, Andersen K, et al, for the Neurologic Diseases in the Elderly Research Group. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology. 2000;54: S10-S15.
15. Guo Z, Fratiglioni L, Zhu L, Fastbom J, Winblad B, Viitanen M. Occurrence and progression of dementia in a community population aged 75 years and older: Relationship of antihypertensive medication use. Arch Neurol. 1999;56:991-996.
16. Letenneur L, Launer LJ, Andersen K, et al, for the EURODEM Incidence Research Group. Education and the risk for Alzheimer's disease: Sex makes a difference: EURODEM pooled analyses. Am J Epidemiol. 2000;151:1064-1071.
17. Dufouil C, Tzourio C, Brayne C, Berr C, Amouyel P, Alperovitch A. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology. 2000;11:280-284.
18. Launer LJ, Andersen K, Dewey ME, et al, for the EURODEM Incidence Research Group and Work Groups, European Studies of Dementia. Rates and risk factors for dementia and Alzheimer's disease: Results from EURODEM pooled analyses. Neurology. 1999;52:78-84.
19. Ott A, Breteler MM, van Harskamp F, Stijnen T, Hofman A. Incidence and risk of dementia: The Rotterdam Study. Am J Epidemiol. 1998;147:574-580.
20. Paykel ES, Huppert FA, Brayne C. Incidence of dementia and cognitive decline in over-75s in Cambridge: Overview of cohort study. Soc Psychiatry Psychiatr Epidemiol. 1998;33:387-392.
21. Waite LM, Broe GA, Grayson DA, Creasey H. The incidence of dementia in an Australian community population: The Sydney Older Persons Study. Int J Geriatr Psychiatry. 2001;16:680-689.
22. , Jorm AF, Jolley D. The incidence of dementia: A meta-analysis. Neurology. 1998;51:728-733.
23. Teng EL, Hasegawa K, Homma A, et al. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. IntPsychogeriatr. 1994;6:45-62.
24. Jorm AF, Christensen H, Henderson AS, Jacomb PA, Korten AE, Mackinnon A. Informant ratings of cognitive decline of elderly people: Relationship to longitudinal change on cognitive tests. Age Ageing. 1996;25:125-129.
25. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968;114:797-811.
26. Blessed G, Tomlinson BE, Roth M. Blessed-Roth Dementia Scale (DS). Psycho-pharmacol Bull. 1988;24:705-708.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
28. Larson EB, Kukull WA, Teri L, et al. University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging (Milano). 1990;2:404-408.
29. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
30. Letenneur L, Commenges D, Dartigues JF, Barberger-Gateau P. Incidence of dementia and Alzheimer's disease in elderly community residents of southwestern France. Int J Epidemiol. 1994;23:1256-1261.
31. Andersen K, Lolk A, Nielsen H, Andersen J, Olsen C, Kragh-Sorensen P. Prevalence of very mild to severe dementia in Denmark. Acta Neurol Scand. 1997;96:82-87.
32. Szklo M. Population-based cohort studies. Epidemiol Rev. 1998;20:81-90.
33. MacMahon B, Trichopoulos D. Epidemiology: Principles and Methods. 2nd Ed. Boston, Mass: Little Brown & Co; 1996.
34. Rothman KJ, Greenland S. Modern Epidemiology. 2nd ed. Philadelphia, Pa: Lippincott-Raven; 1998.
35. Breslow NE, Day NE. Statistical methods in cancer research, volume 11: The design and analysis of cohort studies. IARC Sci Publ. 1987;82:1-406.
36. Schafer JL. Multiple imputation: A primer. Stat Methods MedRes. 1999;8:3-15.
37. Cox DR. Regression models an life tables (with discussion). J R Statist Soc B.1972;34:187-202.
38. Little RJ, Raghunathan T. On summary measures analysis of the linear mixed effects model for repeated measures when data are not missing completely at random. Stat Med. 1999;18:2465-2478.
39. Zhou XH, Eckert GJ, Tierney WM. Multiple imputation in public health research. Stat Med. 2001;20:1541-1549.
40. Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V, The effect of different diagnostic criteria on the prevalence of dementia. N Engl J Med. 1997;337:1667-1674.
41. Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer's disease greater for women than for men? Am J Epidemiol. 2001;153:132-136.
42. Elias MF, Elias PK, D'Agostino RB, Silbershatz H, Wolf PA. Role of age, education, and gender on cognitive performance in the Framingham Heart Study: Community-based norms. Exp Aging Res. 1997;23:201-235.
43. Evans DA, Hebert LE, Beckett LA, et al. Education and other measures of socio-economic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol. 1997;54:1399-1405.
44. Ott A, van Rossum CT, van Harskamp F, van de Mheen H, Hofman A, Breteler MM. Education and the incidence of dementia in a large population-based study: The Rotterdam Study. Neurology. 1999;52:663-666.
45. Myers RH, Schaefer EJ, Wilson PW, et al. Apolipoprotein E E4 association with dementia in a population-based study: The Framingham study. Neurology. 1996;46:673-677.
46. Tang MX, Maestre G, Tsai WY, et al. Effect of age, ethnicity, and head injury on the association between APOEgenotypes and Alzheimer's disease. Ann NY Acad Sci. 1996;802:6-15.
47. Slooter AJ, Cruts M, Kalmijn S, et al. Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: The Rotterdam Study. Arch Neurol. 1998;55:964-968.
48. Ganguli M, Chandra V, Kamboh MI, et al. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol. 2000;57:824-830.
49. Hunt JR, White E. Retaining and tracking cohort study members. Epidemiol Rev. 1998;20:57-70.